1 |
Kala P, Vaňourková Z, Škaroupková P, Kompanowska-Jezierska E, Sadowski J, Walkowska A, Veselka J, Táborský M, Maxová H, Vaněčková I, Červenka L. Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5/6 nephrectomized rats with aorto-caval fistula. Biomed Pharmacother 2023;158:114157. [PMID: 36580726 DOI: 10.1016/j.biopha.2022.114157] [Reference Citation Analysis]
|
2 |
Kala P, Gawrys O, Miklovič M, Vaňourková Z, Škaroupková P, Jíchová Š, Sadowski J, Kompanowska-Jezierska E, Walkowska A, Veselka J, Táborský M, Maxová H, Vaněčková I, Červenka L. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension. J Hypertens 2023;41:99-114. [PMID: 36204993 DOI: 10.1097/HJH.0000000000003307] [Reference Citation Analysis]
|
3 |
Imig JD, Cervenka L, Neckar J. Epoxylipids and soluble epoxide hydrolase in heart diseases. Biochem Pharmacol 2022;195:114866. [PMID: 34863976 DOI: 10.1016/j.bcp.2021.114866] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
4 |
Honetschlägerová Z, Hejnová L, Novotný J, Marek A, Červenka L. Effects of Renal Denervation on the Enhanced Renal Vascular Responsiveness to Angiotensin II in High-Output Heart Failure: Angiotensin II Receptor Binding Assessment and Functional Studies in Ren-2 Transgenic Hypertensive Rats. Biomedicines 2021;9:1803. [PMID: 34944619 DOI: 10.3390/biomedicines9121803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|